Wed. Jun 19th, 2019

How ‘female viagra’ could disrupt the $6bn sexual dysfunction industry

Sprout CEO Cindy Eckert launched the world's first drug approved to treat female sexual dysfunction and in 2015 sold it to Valeant for $1 billion. Three years later, she sued Valeant to regain control and relaunched the drug at half the price.

Leave a Reply

Your email address will not be published. Required fields are marked *